BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20469607)

  • 1. Heart transplantation is not the only option for patients with advanced heart failure.
    Barcena JA; Fang J
    Hosp Pract (1995); 2010 Apr; 38(2):7-8. PubMed ID: 20469607
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart transplant vs left ventricular assist device in heart transplant-eligible patients.
    Williams ML; Trivedi JR; McCants KC; Prabhu SD; Birks EJ; Oliver L; Slaughter MS
    Ann Thorac Surg; 2011 May; 91(5):1330-3; discussion 1333-4. PubMed ID: 21439545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future is here: ventricular assist devices for the failing heart.
    Alba AC; Delgado DH
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1067-77. PubMed ID: 19764860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The next treatment option: using ventricular assist devices for heart failure.
    Stahovich M; Chillcott S; Dembitsky WP
    Crit Care Nurs Q; 2007; 30(4):337-46. PubMed ID: 17873570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular assist device therapy.
    Sayer G; Naka Y; Jorde UP
    Cardiovasc Ther; 2009; 27(2):140-50. PubMed ID: 19426251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destination therapy: patient selection and current outcomes.
    Lietz K
    J Card Surg; 2010 Jul; 25(4):462-71. PubMed ID: 20529162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist devices in heart failure.
    Kilic A; Ailawadi G
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):649-56. PubMed ID: 22651840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovation with experience using implantable left ventricular assist devices.
    Ascheim DD; Gelijns AC; Rose EA
    Circ Heart Fail; 2009 Jan; 2(1):1-2. PubMed ID: 19808308
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First experience of application of assist circulation device using biventricular type "excor"].
    Gordeev ML; Karpenko MA; Nikolaev GV; Gnevashev AS; Malaia EIa; Naĭmushin AV; Rubinchik VE; Sukhova IV; Mitrofanova LB; Somin MIu; Sazonova IuV; Stepanov SS; Fedotov PA
    Vestn Khir Im I I Grek; 2013; 172(5):71-6. PubMed ID: 24640753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient selection for ventricular assist devices: a moving target.
    Miller LW; Guglin M
    J Am Coll Cardiol; 2013 Mar; 61(12):1209-21. PubMed ID: 23290542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanical devices in the treatment of severe heart failure].
    Pakarinen S; Lommi J
    Duodecim; 2005; 121(11):1217-24. PubMed ID: 15999981
    [No Abstract]   [Full Text] [Related]  

  • 16. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart transplantation and long-term mechanical support in Japan: progress at last.
    Kato TS; Komamura K; Naka Y
    J Heart Lung Transplant; 2011 Sep; 30(9):1070. PubMed ID: 21620735
    [No Abstract]   [Full Text] [Related]  

  • 19. Projected survival benefit as criterion for listing and organ allocation in heart transplantation.
    Krakauer H; Lin MJ; Bailey RC
    J Heart Lung Transplant; 2005 Jun; 24(6):680-9. PubMed ID: 15949727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective.
    Copeland JG
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):228-30. PubMed ID: 12579089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.